DEA Archived Press Releases

Press Releases before January 20, 2025
385 Results - Showing 201 to 210
PRESS RELEASE

DEA Bolsters Fight Against Opioid Crisis With 250 Additional Task Force Officers

WASHINGTON - The Drug Enforcement Administration will add 250 task force officers and dozens of additional analysts to areas across America where the opioid crisis is at its worst. DEA task forces act as a force multiplier in carrying out DEA’s mission through coordination and cooperation with federal, state, and...
PRESS RELEASE

DEA announces the establishment of a new Division Office in Omaha

(OMAHA, Neb.) – The Drug Enforcement Administration will establish the Omaha Field Division – its 23rd division office in the United States – on July 8, 2018. The division will include Nebraska, Iowa, Minnesota, North Dakota and South Dakota. “This action converts the existing Omaha District Office into a division...
PRESS RELEASE

DEA, Dutch Law Enforcement Continue Attack On Dark Web Drug Sales

THE HAGUE - The United States Drug Enforcement Administration and Dutch law enforcement officials today announced sustained action against drug trafficking on the dark web, following last summer’s significant market takedowns of AlphaBay and takeover and subsequent takedown of the Hansa market. DEA continued to partner with the National Police...
PRESS RELEASE

DEA Creates New Resource To Help Distributors Avoid Oversupplying Opioids

WASHINGTON - The U.S. Drug Enforcement Administration has launched a new tool to assist drug manufacturers and distributors with their regulatory obligations under the Controlled Substances Act. This new resource is an example of the many ways DEA is working collaboratively with its 1.73 million registrants to combat the ongoing...
PRESS RELEASE

U.S. Drug Enforcement Administration Emergency Schedules All Illicit Fentanyls In An Effort To Reduce Overdose Deaths

WASHINGTON - The U.S. Drug Enforcement Administration this week placed all illicit fentanyl analogues not already regulated by the Controlled Substances Act into Schedule I-the category for substances with no currently accepted medical use-for two years, with the possibility of a one-year extension. This action is expected to reduce these...
PRESS RELEASE

Lubbock Man Sentenced To More Than 21 Years In Federal Prison For Distributing Cocaine

LUBBOCK, Texas - Gregory Jerome Mitchell, a.k.a “Jimmy Jombo Kalu,” 33, was sentenced on January 19, 2018 by Senior U.S. District Judge Sam R. Cummings to 262 months in federal prison for distributing cocaine, announced Special Agent-in-Charge Clyde E. Shelley, Jr. of the DEA and U.S. Attorney Erin Nealy Cox...
PRESS RELEASE

Attorney General Sessions Delivers Remarks At Special Agent Graduation Ceremony

WASHINGTON - Attorney General Jeff Sessions travelled to the FBI Academy on Marine Corps Base Quantico, Virginia, on Friday, January 26, 2018, to deliver remarks to graduates of the Drug Enforcement Administration Basic Agent Trainee class. Attorney General Sessions was hosted by DEA’s Acting Administrator Robert Patterson and Training Division...
PRESS RELEASE

DEA Announces Step To Increase Opioid Addiction Treatment

WASHINGTON - The United States Drug Enforcement Administration today announced a deregulatory measure that will make it easier for residents of underserved areas to receive treatment for opioid addiction. As published today in the Federal Register, nurse practitioners and physician assistants can now become DATA-Waived qualifying practitioners, which gives them...
PRESS RELEASE

DEA Investigation Unravels Drug Trafficking And Corruption By Honduran Congressman

WASHINGTON - A member of the Honduran National Congress faces U.S. charges for drug trafficking, weapons and conspiracy thanks to a DEA-led international drug investigation, federal law enforcement officials announced today. Honduran Congressman Fredy Renan Najera Montoya has been charged in Manhattan federal court with conspiring to import cocaine into...
PRESS RELEASE

DEA Speeds Up Application Process For Research On Schedule I Drugs

WASHINGTON - The Drug Enforcement Administration is streamlining the application process for researchers who study or wish to study Schedule I substances not currently approved for medical use. Schedule I drugs are defined as drugs, substances, or chemicals with no accepted medical use and a high potential for abuse, such...